Jules Mitchel Receives PharmaVOICE Red Jacket Award

 

This past week, PharmaVOICE honored their PharmVOICE 100 and Red Jacket awards at the Alexandria Center in NYC. Target Health is pleased to announce that Jules Mitchel, President of Target Health Inc. received the coveted Red Jacket Award, together with Jim Curtis, Remedy Health Media; Cameron Durrant, M.D., Humanigen Inc.; Terry Herring Mission Pharmacal; Brian Loew, Inspire; Matt McNally, Publicis Health; and Wendy White, Wendy White Consulting.

 

RBM 2017 Meeting: Risk-Based Trial Management and Monitoring

 

On November 2-3, 2017, Dr. Mitchel will be presenting at CBI’s “RBM 2017 Meeting: Risk-Based Trial Management and Monitoring,“ being held at the Warwick Rittenhouse Square | Philadelphia, PA. The conference theme is: Enhance Process and System Interoperability to Optimize Data Quality, Improve Trial Efficiency and Ensure Compliance.

 

Dr. Mitchel’s topic is “RBM Risk Assessment – What Risks Are We Assessing from the Patient, Study, Site and Sponsor Perspectives?“ In summary, assessing risk is an ongoing process for any industry, and clearly the impact of all risks are not equal. In the clinical research environment, the primary concern is the safety risk to the patient when taking an experimental medicinal product or using an unapproved medical device. Other risks include the impact of not following the protocol and not being complaint with rules and regulations.

 

This session will present a model for risk assessment and will provide concrete examples of risk factors such as:

 

1. the severity of the event, should it happen

2. the likelihood that the event would happen

3. the likelihood of detecting the event

4. risk mitigation strategies for each risk

5. Assessment of unique risks associated with specific studies

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

Our hopes and prayers are for those suffering due to the terrible storms going on now in the US, as well as those suffering all over the world. While the tornado this week in New London, Connecticut, reported below, was not as bad as Hurricane Harvey, Hurricane Irma, the terrible earthquake in Mexico and other global disasters due to CLIMATE CHANGE, the world leaders must take heed.  If not, We The People must take charge of our planet. And yes, we still have to reckon with Hurricane Katia in the Gulf of Mexico, and Hurricane Jose which could hit the East Coast of the US. 

In 2006, a study by NASA, published in the Proceedings of the National Academy of Sciences, and authored by Dr. James Hansen of NASA’s Goddard Institute for Space Studies (now a Professor at the Earth Institute at Columbia University), and colleagues from Columbia University, Sigma Space Partners, Inc., and the University of California at Santa Barbara (UCSB), reported that the world’s temperature is reaching a level that has not been seen in thousands of years.  The study concluded that, because of a rapid warming trend over the past 30 years, the Earth is now reaching and passing through the warmest levels in the current interglacial period, which has lasted nearly 12,000 years. This warming is forcing a migration of pathogens, plants and animal species toward the poles.

Listen to a recent interview with Dr. James Hansen.

Listen to Dr. Paul Beckwith, Professor of Climatology at the University of Ontario, talking yesterday about Hurricane Irma.

Climate Change Disrupts all Varieties of Transportation

On Wednesday, 6 September 2017, Target Health took off to attend the DPharm Meeting in Boston. Fortunately, Les Jordan our Chief Software Evangelist, lives in the Boston area.  However, it took Warren Pearlson, BD Director, 8 hours to get to Boston and Jules Mitchel, 6 hours. The tornado in New London, unfortunately, landed on the home of Dave Luke, Sr. Director of Clinical and Scientific Affairs. This same tornado, landed trees onto the train tracks, which caused the lengthy train delays.  A tornado in Connecticut is a rare event.

Our full ON TARGET Newsletter will resume next week.

 

 

Jules Mitchel Receives Red Jacket Award and Time For a Vacation

 

To our loyal readers, friends and colleagues: We are taking time off from the last half of August and the first half of September. See you in September. We started ON TARGET in 1994, first sending the newsletter out by fax. Our weekly newsletter is now being shared with over 6,000 readers each week.

 

For more than a dozen years, PharmaVOICE magazine has been recognizing the most inspirational, motivational, and transformative individuals throughout the life-sciences industry in its annual July/August PharmaVOICE 100 issue. These individuals illustrate what it means to think bigger, do more, and lead with passion and integrity. This year’s distinguished honorees were nominated by thousands of PharmaVOICE readers and were selected for inclusion based on substantive accounts describing how they have inspired or motivated their colleagues, peers, and even competitors; their positive impact on patients, their organizations, and the industry at large; their innovative and game-changing strategies and thinking; their mentorship and guidance to the next generation of leaders; as well as their willingness to give their time and resources to their communities and philanthropic causes. The PharmaVOICE 100 is the premier awards program whose honorees represent a broad cross section of the global life-sciences industry, including the pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, advertising, digital, marketing, technology, academia, as well as multiple other sectors. This diverse group of individuals is also unique in that they represent a wide variety of functional areas – ranging from the clinic to the C-suite.

 

Please join the Celebration on September 14 in New York City, where PharmaVoice will be recognizing this year’s honorees as well as PharmaVOICE 100 honorees throughout the years. This is the one event designed to encourage collaboration and networking among a diverse and executive leadership audience. For more details about the third annual PharmaVOICE 100 Celebration, please go to: http://www.pharmavoice.com/pv100-celebration.

 

One of the criteria for being named a Red Jacket is having been recognized previously as a PharmaVOICE 100 honoree, but it’s much more than that. These individuals, who cross a multitude of industry sectors, have raised the bar in terms of what it means to be an inspired leader for their teams, their companies, their communities, and for the industry at large.

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

Target Health Joins Charity Event Sponsored by the Nippon Club and JCCI

 

The 14th Annual Gala Music and Dinner Cruise. A special Charity event presented by the Nippon Club and JCCI and – July 18, 2017. A Special Charity event at Hudson River Park Pier 40, New York City

 

The Japanese Chamber of Commerce and Industry of New York, Inc. shared the video from the evening in the YouTube link. If you look closely at this video, you can catch glimpses of Target Health Inc.’s Representative Mui Ying Kwan, at the event. Ms. Kwan also took all of the photographs.

 

This summer, Target Health Inc., a member of the Nippon Club for 27 years, managed to stay cool, be philanthropic and at the same time participate in the 14th Annual music and dinner cruise presented by the Nippon club in collaboration with the Japanese Chamber of Commerce and Industry (JCCI) of New York. Sponsors include companies such as American Airlines, Mitsubishi and Hitachi America. The Annual special charity cruise is in support of the Japanese American social services, Inc (JASSI). Established in 1981, JASSI aim to improve the quality of life of people living in the NY tri-state area through workshops, hotlines and recreational events on Health insurance, emergency preparedness, hospital procedures, immigration and suicide prevention. All these services are provided for no fee whatsoever to both young and old.

 

The cruise set sail from Hornblower Landing at the Hudson River Park, Pier 40 this past Tuesday evening. There was a buzz of excitement and anticipation as passengers boarded the ship and the boat began to depart. The hors d’oeuvre, such as Butterfly shrimp with mango salsa and fresh asparagus tips wrapped in smoked salmon with a light dusting of bonito flakes served during the cocktail reception were delectable. The passengers toasted their glasses while looking out at the spectacular views of New York City. The cruise got off to a fast start with a sea of architectural skyscrapers flashing by. There was the Freedom Tower, the Empire State Building and then suddenly the Brooklyn Bridge! After the reception, the guests took their seats in the dining area while Rebecca Cass, the coordinator of Japanese Chamber of commerce and industry (JCCI) of New York, gave her warm welcome

 

During the three-course dinner, the diners at each table introduced themselves to one another. Target Health’s cultural liaison was sitting next to a wonderful long time philanthropic couple and across from Terumusa Yamada, president of Ad-Boutique, a digital graphics company based in Manhattan and his colleague. Mr. Yamada’s clients include the Nippon club. In addition to the magnificent views of the New York Skyline and the Statue of Liberty, there were two lively performances during dinner.

 

The first performance were the Taiko drums. call Soh-Daiko a Taiko drumming group on the east coast that was established in 1979 in New York. The inspiring repertoire included compositions from the Japanese Shinto music tradition. Also, presented were Taiko arrangements combined with modern compositions from the group members. Next came a dance performance of the Bon Odori, a traditional local Japanese dance also known as the Festival of Souls. The dance is usually performed during the summer around July, around the Obon Festival, which is a Japanese Buddhist custom to honor the spirits of ancestors. Originally a Nenbutsu folk dance to welcome the spirits of dead. The dance varies from each region in Japan. The typical Bon dance consist of people dancing in a circle.

 

After the performance, the guests were encouraged to learn the Bon Odori style dance and danced to music in a large circle. At the end of the dinner and dancing, it was time for the charity raffle drawing. The raffle prizes included a 4 pairs of round trip tickets to any American Airlines destination, a stay at New York Hilton Midtown or a weekend at Kitano hotel. An iPad mini and Shiseido gift bags. A dining neighbor, Mr. Terumusa Yamada president of AD-Boutiques Inc. in New York City turned out to be the lucky Winner of the night. He won two prizes one of which is the grand prize- a pair of round trip tickets to any American Airlines destination. It was a festive evening filled with wonderful food, music, dance and great raffle prizes – a perfect end to the month of July.

 

This is the beginning of the gala Nippon Club Charity Dinner Cruise. Guest lining up to board the cruise for the 14th annual music and dinner Charity cruise at Hornblower Landing at Hudson River Park Pier 40. © Target Health Inc.

 

Charity dinner cruise at Hudson River Park Pier 40, New York City: Some of the guest are wearing Yakuta, casual kimono for the summer. Complimentary hand fans are handed out prior to boarding the cruise. © Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Guest on board are enjoying themselves at the cocktail reception just prior to departure. © Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: After the cocktail reception the guests were seated for a 3-course dinner while enjoying the amazing views of the city. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Mr. Terumasa Yamada of Ad-Boutique Inc., a New York graphics company enjoying the splendid views of New York city. ©Target Health Inc.

 

At a lovely table by the window, guests are enjoying themselves at the Nippon Club Charity Dinner Cruise. Here sipping a cool cocktail, is Mui Ying Kwan, Cultural Liaison at Target Health Inc. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Welcome remarks and check presentation for the Japanese American Social Services Inc (Jassi). Hosted by Rebecca Cass coordinator of the Japanese Chamber of commerce and industry (JCCI) with Hideki Kungungi, from Nippon Airways dinner chairman. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Presentation of the check in which the portion of the proceeds from this year’s music and dinner cruise from contributors and sponsors will go to the Japanese American social services, Inc. established in 1981, the Japanese American social services, Inc. aim to improve the quality of life of people living in the NY tri-state area through workshops, hotlines and recreational events on Health insurance, emergency preparedness, hospital procedures, immigration and suicide prevention. All these services are provided for no fee whatsoever to both young and old. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Target Health on the cruise with Rebecca Cass, the coordinator of Japanese Chamber of commerce and industry (JCCI) of New York. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Socializing with long time Patrons of the Nippon club and JJCI. Target Health Inc. Cultural Liaison is on the right. ©Target Health Inc.

 

 

City Views

Happy guests as the Nippon Club Charity Dinner Cruise pulls out of the harbor. © Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: passengers taking pictures of the city. © Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Close-up of the Brooklyn Bridge. © Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Passing the iconic Statue of liberty. © Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise at night on the Hudson, New York City. © Target Health Inc.

 

Dinner and Cocktails

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: The passengers toast their glasses of champagne with strawberries as the cruise takes off. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: The three-course dinner starts out with a delicious butter lettuce salad drizzled with a generous amount of lemon chive vinaigrette. Mmmm © Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: The dinner entr?e of seared pepper crusted sirloin and herb crusted salmon served with tomato squash Gratin, whipped Yukon Potatoes and wild mushroom Demi-Glace is perfectly paired with a refreshing glass of Sauvignon Blanc. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Dessert of cheese cake with whipped cream, fresh strawberries and of course, more champagne. ©Target Health Inc.

 

Great Performances

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: A riveting musical performance by Soh-Daiko a Taiko drumming group on the east coast that was established in 1979 under the guidance of the New York Buddhist church. The repertoire includes inspiration from the compositions from the Japanese Shinto music tradition, Taiko arrangements combined with the modern compositions from the group members. © Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Taiko drumming mixing traditional Japanese Shinto music with modern compositions. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: The second part of the entertainment is a dance performance call Bon Odori, a traditional Japanese dance performed during the summer around Obon to welcome the spirits of deceased back. The typical Bon dance consist of people dancing in a circle. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: After the performance, the guest are encouraged to learn the Bon Odori style dance. Guests are dancing to music in a large circle. © Target Health Inc.

 

Lucky Winners of the raffle drawing

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Terumusa Yamada president of AD-Boutiques Inc. is the lucky winner of the night. Winning two prizes. Here he is holding the winning raffle tickets with his colleague. ©Target Health Inc.

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Terumusa Yamada president of AD-Boutiques Inc. in New York City is the lucky Winner of the night, winning the grand prize – a pair of round trip tickets to any American Airlines destination. ©Target Health Inc

 

Nippon Club & JCCI’s Dinner Cruise on the Hudson, New York City: Beautiful sunset for a gala occasion! © Target Health Inc.

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website, and if you like the weekly newsletter, ON TARGET, you’ll love the Blog.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

Target e*Studio® (EDC Builder) Now Includes Target e*ICD™ (Informed Consent)

 

Target e*CRF® has been used in multiple clinical trials and multiple FDA, EMA, HC and global regulatory approvals, for drugs, biologics, devices and diagnostics (including companion diagnostics). Our patented direct data entry eSource solution has also revolutionized clinical trial operations where in most cases, 80-90% of data are entered in real time, and onsite monitoring has dropped by over 60%. You can do the math.

 

The whole clinical trial can now be managed at one website, including direct data entry capture (eSource), risk-based monitoring, randomization, drug supply management, SAE management, monitoring reports etc. We give you what is needed, no more, no less.

 

Based our approval record and regulatory inspection success, our software delivers virtually everything needed to run the daily requirements of a clinical trial. Already this year, our software was used in an approved NDA, as well as for an expansion of an indication of a de novo 510(k) device, to include all patients receiving chemotherapy who are at risk for hair loss.

 

Of course, there is always the need to grow and this past year we added Target e*ICD™ (Informed Consent Document) and successfully completed the study with 65% of subjects, in a dermatology indication, signing electronically.

 

Version Control

 

To make clinical trials even more efficient, we are building the next version of Target e*Studio in order to accommodate and facilitate the needs of academic studies, research fellows, smaller CROs, biotech startups, as well as big pharma and global CROs. What makes us different is our deep knowledge of the clinical trial space, as well as tangible successes over the last 18 years that Target e*CRF has been used for clinical trials.

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

NIH Collaboratory Webinar: John Laschinger, MD and Jules Mitchel, PhD to Present the CTTI Registry Trial Project

 

Target Health has been a member of the Clinical Trials Transformation Initiative (CTTI) since 2008, and we strongly support CTTI’s mission of transforming and modernizing clinical trials. While it has been a long journey, there have been many fruits of our labors, including the Registry Work Stream, which culminated in a CTTI Webinar in May, and now an NIH Collaboratory Webinar being held this month.

 

Here are the Collaboratory details:

 

On Friday, July 21, 2017, 1:00-2:00 p.m. EDT, John Laschinger, MD, Medical Officer, Center for Devices and Radiological Health, Clinical Trials Operations and Biostatistics Branch, US FDA, and Jules Mitchel, MBA, PhD, President, Target Health Inc. will be presenting the “CTTI Registry Trials Project: Evaluation and Design of Registries for Conducting Clinical Trials.“ For more information go to https://www.nihcollaboratory.org/Lists/Calendar/DispForm.aspx?ID=253.

 

This webinar covers CTTI’s recommendations on conducting clinical trials using registries. Those interested in evaluating or designing a registry for the purposes of conducting clinical trials can learn more about the project’s tools, intended for the following purposes:

 

1. To determine if an existing registry is appropriate for embedding clinical trials

2. To assess if an existing registry contains the elements needed to support a clinical trial

3. To design a new registry suitable for embedding clinical trials

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website, and if you like the weekly newsletter, ON TARGET, you’ll love the Blog.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

DIA 2017 and James Farley Photograph

 

We are back from the annual DIA meeting in Chicago, and it was quite a success. Our presentation on How eSource Solutions are Impacting Clinical Research Sites, Patients, Regulators and Drug and Device Companieswith Jonathan Helfgott and Mitchell Efros, was well-attended and quite stimulating.

 

Two-Striped Grasshopper – James Farley Photographer Par Excellence

Two-Striped Grasshopper – ©JFarley Photography.

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

Scott Mellis, MD, PhD on Safari

 

Our very good friend and colleague, Dr. Scott Mellis, Vice President, Early Clinical Development and Experimental Sciences, Rare Diseases at Regeneron Pharmaceuticals, took an adventurous trip to Africa and came back with some extraordinary photos.

Cheetahs enjoying a family meal in the Serengeti. ©Scott Mellis, M.D., Ph.D.

 

Lion outside safari vehicle.  Ngoro Ngoro crater © Scott Mellis, M.D., Ph.D.

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

DIA Annual Meeting – See Us at Booth 913

 

We hope to see you in Chicago and join us on our couches.

A reminder that Dr. Jules T. Mitchel will be chairing a Content Hub presentation / conversation which will take place at the DIA Annual Meeting in Chicago. Please join us at 4pm on Tuesday June 20, 2017 at the S400 Concourse. The topic is:

 

How eSource Solutions are Impacting Clinical Research Sites, Patients, Regulators and Drug and Device Companies

 

Co-presenting will be our colleagues and friends:

 

Jonathan Helfgott, MS, who is currently the Coordinator of the Regulatory Science Graduate Program at Johns Hopkins University, and previously the Associate Director for Risk Science at FDA CDER OSI and the main author of FDA’s eSource Guidance, and;

 

Mitchell D. Efros MD FACS, CEO of Verified Clinical Trials

 

The following is an outline of the presentation and we look forward to seeing you there:

 

In the not too distant future, we, as an industry will execute, manage and monitor clinical trials the same way we execute, manage and monitor banking transactions online, quickly and without the need to maintain paper records. However, as we bring new and innovative technology solutions to the market, we must assess and address the concerns of all the stakeholders within the clinical trial enterprise. We need to assure patients, clinical research sites, pharmaceutical and device companies, as well as regulators, that there will be improved efficiencies, improved data quality and integrity, improved patient safety, reduced fraud and an overall better experience during the clinical trial process. Topics to be addressed include clinical site acceptance, regulatory concerns, software validation, risk assessments, change management within companies, and a comprehensive assessment of the risks and rewards.

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

DIA Annual Meeting Presentation on the Paperless Clinical Trial and its Impact on the Clinical Trial Enterprise

 

Target Health Inc. is pleased to announce that Dr. Jules T. Mitchel will be chairing a Content Hub presentation/conversation which will take place during DIA Annual Meeting in Chicago. Please join us at 4pm on Tuesday June 20, 2017 at the S400 Concourse. The topic is:

 

How eSource Solutions are Impacting Clinical Research Sites, Patients, Regulators and Drug and Device Companies

 

Co-presenting will be our colleagues and friends:

 

Jonathan Helfgott, MS, who is currently the Coordinator of the Regulatory Science Graduate Program at Johns Hopkins University, and previously the Associate Director for Risk Science at FDA CDER OSI and the main author of FDA’s eSource Guidance, and;

 

Mitchell D. Efros MD FACS, CEO of Verified Clinical Trials

 

The following is an outline of the presentation and we look forward to seeing you there:

 

In the not too distant future, we as an industry will execute, manage and monitor clinical trials the same way we execute, manage and monitor banking transactions online, quickly and without the need to maintain paper records. However, as we bring new and innovative technology solutions to the market, we must assess and address the concerns of all of the stakeholders within the clinical trial enterprise. We need to assure patients, clinical research sites, pharmaceutical and device companies, as well as regulators, that there will be improved efficiencies, improved data quality and integrity, improved patient safety, reduced fraud and an overall better experience during the clinical trial process. Topics to be addressed include clinical site acceptance, regulatory concerns, software validation, risk assessments, change management within companies, and a comprehensive assessments of the risks and rewards.

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

Next Page →